Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219104 | 0.84 | ALDH1A1 (0.47) | ALDH1A1ALOX15TSHR | |
| SCHEMBL1598822 | 0.84 | ALDH1A1 (0.47) | ALDH1A1ALOX15TSHR | |
| SCHEMBL9471045 | 0.77 | ALDH1A1 (0.39) | ALDH1A1ALOX15TSHR | |
| SCHEMBL8581211 | 0.77 | — | — | |
| SCHEMBL4048252 | 0.73 | — | — | |
| SCHEMBL8635855 | 0.72 | — | — | |
| SCHEMBL30166648 | 0.72 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL30861998 | 0.72 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL15444652 | 0.72 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR | |
| SCHEMBL20267103 | 0.72 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119776014-A | Tobacco continuous cropping soil regulator and preparation method thereof | 台沃科技集团股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-8580802-B2 | Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-11-12 | — | — | US | disclosed |
| US-20070207995-A1 | Deazapurines useful as inhibitors of Janus kinases | VERTEX PHARMACEUTICALS INCORPORATED | 2007-09-06 | — | — | US | disclosed |
| US-5463031-A | Printing, dyeing cellulose and organonitrogen compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1995-10-31 | — | — | US | disclosed |
| US-5233105-A | Fluorination using hydrogen fluoride | BAYER AKTIENGESELLSCHAFT (DE) | 1993-08-03 | — | — | US | disclosed |
| US-4161593-A | Process for the preparation of triazines containing a mixture of chlorine and fluorine substituents, and of cyanuric fluoride | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-17 | — | — | US | disclosed |
| US-4052386-A | REACTIVE PHTHALOCYANINE DYESTUFFS CONTAINING A FLUOROPYRIMIDINYL GROUP | BAYER AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070207995-A1 | Deazapurines useful as inhibitors of Janus kinases | JAK1, JAK3, JAK2 | ALDH1A1 2028/4885ALOX15 2548/4885TSHR 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.